Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine if AZD8931 can be safely administered in
Japanese patients alone and in combination with weekly paclitaxel. The study will be
conducted in two parts: a monotherapy and a combination part, where safe doses of study
treatment will be determined.